APRE
Aprea Therapeutics Inc
NASDAQ: APRE · HEALTHCARE · BIOTECHNOLOGY
$0.82
-2.14% today
Updated 2026-04-29
Market cap
$9.81M
P/E ratio
—
P/S ratio
34.34x
EPS (TTM)
$-1.93
Dividend yield
—
52W range
$1 – $2
Volume
0.5M
Aprea Therapeutics Inc (APRE) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2007 | 2012 | 2013 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $67868.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $583231.00 | $1.50M | $285759.00 |
| Revenue growth (YoY) | — | -100.0% | — | — | — | — | — | — | — | — | +157.6% | -81.0% |
| Cost of revenue | $13411.00 | $0.00 | $0.00 | $7932.00 | $8316.00 | $170254.00 | $229610.00 | $271677.00 | $16.40M | $7052.00 | $9.36M | $21715.00 |
| Gross profit | $54457.00 | $0.00 | $0.00 | $-7932.00 | $-8316.00 | $-170254.00 | $-229610.00 | $-271677.00 | $-16.40M | $576179.00 | $-7.86M | $264044.00 |
| Gross margin | 80.2% | — | — | — | — | — | — | — | — | 98.8% | -523.2% | 92.4% |
| R&D | — | — | — | $13.39M | $14.19M | $20.95M | $37.88M | $23.90M | $92.42M | $7.63M | $9.36M | $7.04M |
| SG&A | $3.22M | $21333.00 | $246491.00 | $2.46M | $2.29M | $8.59M | $14.93M | $13.55M | $20.97M | $8.43M | $6.46M | $6.48M |
| Operating income | $-3.17M | $-21333.00 | $-246491.00 | $-15.85M | $-16.49M | $-29.54M | $-52.81M | $-37.45M | $-113.39M | $-15.47M | $-14.32M | $-13.23M |
| Operating margin | -4670.1% | — | — | — | — | — | — | — | — | -2652.8% | -953.0% | -4631.1% |
| EBITDA | — | — | — | $-15.18M | $-15.52M | $-27.89M | $-53.25M | $-36.86M | $-37.37M | $-14.28M | $-14.30M | $-13.23M |
| EBITDA margin | 0.0% | — | — | — | — | — | — | — | — | -2448.4% | -951.5% | -4631.1% |
| EBIT | $-3.17M | $-21333.00 | $-246491.00 | $-15.19M | $-15.53M | $-28.06M | $-53.48M | $-37.13M | $-37.37M | $-14.29M | $-14.32M | $-13.26M |
| Interest expense | $0.00 | $0.00 | $0.00 | $15.00 | $182.00 | $156351.00 | $222652.00 | $1648.00 | $448667.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-3.52M | $-254006.00 | $-436215.00 | $-15.19M | $-15.53M | $-28.06M | $-53.92M | $-36.54M | $-112.66M | $-14.29M | $-12.96M | $-12.60M |
| Net income growth (YoY) | — | +92.8% | -71.7% | -3382.3% | -2.2% | -80.7% | -92.1% | +32.2% | -208.4% | +87.3% | +9.3% | +2.8% |
| Profit margin | -5193.1% | — | — | — | — | — | — | — | — | -2449.6% | -862.4% | -4409.2% |